Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Characteristics and clinical assessment of unexplained sudden cardiac arrest in the real-world setting: focus on idiopathic ventricular fibrillation

Characteristics and clinical assessment of unexplained sudden cardiac arrest in the real-world... AimsRecent studies have shown that in more than half of apparently unexplained sudden cardiac arrests (SCA), a specific aetiology can be unmasked by a careful evaluation. The characteristics and the extent to which such cases undergo a systematic thorough investigation in real-life practice are unknown.Methods and resultsData were analysed from an ongoing study, collecting all cases of out-of-hospital cardiac arrest in Paris area. Investigations performed during the index hospitalization or planned after discharge were gathered to evaluate the completeness of assessment of unexplained SCA. Between 2011 and 2016, among the 18 622 out-of-hospital cardiac arrests, 717 survivors (at hospital discharge) fulfilled the definition of cardiac SCA. Of those, 88 (12.3%) remained unexplained after electrocardiogram, echocardiography, and coronary angiography. Cardiac magnetic resonance imaging yielded the diagnosis in 25 (3.5%) cases, other investigations accounted for 14 (2.4%) additional diagnoses, and 49 (6.8%) patients were labelled as idiopathic ventricular fibrillation (IVF) (48.7 ± 15 years, 69.4% male). Among those labelled IVF, only 8 (16.3%) cases benefited from a complete workup (including pharmacological testing). Younger patients [odds ratio (OR) 6.00, 95% confidence interval (CI) 1.80–22.26] and those admitted to university centres (OR 3.60, 95% CI 1.12–12.45) were more thoroughly investigated. Genetic testing and family screening were initiated in only 9 (18.4%) and 12 (24.5%) cases, respectively.ConclusionOur findings suggest that complete investigations are carried out in a very low proportion of unexplained SCA. Standardized, systematic approaches need to be implemented to ensure that opportunities for specific therapies and preventive strategies (including relatives) are not missed. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Heart Journal Oxford University Press

Characteristics and clinical assessment of unexplained sudden cardiac arrest in the real-world setting: focus on idiopathic ventricular fibrillation

Download PDF
9 pages

Loading next page...
 
/lp/ou_press/characteristics-and-clinical-assessment-of-unexplained-sudden-cardiac-N3DGruC0Qj
Publisher
Oxford University Press
Copyright
© The Author(s) 2018. Published by Oxford University Press on behalf of the European Society of Cardiology.
ISSN
0195-668X
eISSN
1522-9645
DOI
10.1093/eurheartj/ehy098
Publisher site
See Article on Publisher Site

Abstract

AimsRecent studies have shown that in more than half of apparently unexplained sudden cardiac arrests (SCA), a specific aetiology can be unmasked by a careful evaluation. The characteristics and the extent to which such cases undergo a systematic thorough investigation in real-life practice are unknown.Methods and resultsData were analysed from an ongoing study, collecting all cases of out-of-hospital cardiac arrest in Paris area. Investigations performed during the index hospitalization or planned after discharge were gathered to evaluate the completeness of assessment of unexplained SCA. Between 2011 and 2016, among the 18 622 out-of-hospital cardiac arrests, 717 survivors (at hospital discharge) fulfilled the definition of cardiac SCA. Of those, 88 (12.3%) remained unexplained after electrocardiogram, echocardiography, and coronary angiography. Cardiac magnetic resonance imaging yielded the diagnosis in 25 (3.5%) cases, other investigations accounted for 14 (2.4%) additional diagnoses, and 49 (6.8%) patients were labelled as idiopathic ventricular fibrillation (IVF) (48.7 ± 15 years, 69.4% male). Among those labelled IVF, only 8 (16.3%) cases benefited from a complete workup (including pharmacological testing). Younger patients [odds ratio (OR) 6.00, 95% confidence interval (CI) 1.80–22.26] and those admitted to university centres (OR 3.60, 95% CI 1.12–12.45) were more thoroughly investigated. Genetic testing and family screening were initiated in only 9 (18.4%) and 12 (24.5%) cases, respectively.ConclusionOur findings suggest that complete investigations are carried out in a very low proportion of unexplained SCA. Standardized, systematic approaches need to be implemented to ensure that opportunities for specific therapies and preventive strategies (including relatives) are not missed.

Journal

European Heart Journal – Oxford University Press

Published: Mar 16, 2018

Keywords: Sudden death; Ventricular fibrillation; Workup; Prevention; Genetics; Family

References

  • Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop
    Fishman, GI; Chugh, SS; Dimarco, JP; Albert, CM; Anderson, ME; Bonow, RO; Buxton, AE; Chen, P-S; Estes, M; Jouven, X; Kwong, R; Lathrop, DA; Mascette, AM; Nerbonne, JM; O'Rourke, B; Page, RL; Roden, DM; Rosenbaum, DS; Sotoodehnia, N; Trayanova, NA; Zheng, Z-J.
  • Cardiovascular disease in Europe: epidemiological update 2016
    Townsend, N; Wilson, L; Bhatnagar, P; Wickramasinghe, K; Rayner, M; Nichols, M.
  • European Society of Cardiology: cardiovascular disease statistics 2017
    Timmis, A; Townsend, N; Gale, C; Grobbee, R; Maniadakis, N; Flather, M; Wilkins, E; Wright, L; Vos, R; Bax, J; Blum, M; Pinto, F; Vardas, P.
  • Sudden cardiac death: a better understanting for a better prevention
    Waldmann, V; Bougouin, W; Karam, N; Albuisson, J; Cariou, A; Jouven, X; Marijon , E
  • Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families
    Behr, ER; Dalageorgou, C; Christiansen, M; Syrris, P; Hughes, S; Tome Esteban, MT; Rowland, E; Jeffery, S; McKenna, WJ.
  • Nationwide study of sudden cardiac death in persons aged 1-35 years
    Winkel, BG; Holst, AG; Theilade, J; Kristensen, IB; Thomsen, JL; Ottesen, GL; Bundgaard, H; Svendsen, JH; Haunsø, S; Tfelt-Hansen, J.
  • Genetics of sudden death: focus on inherited channelopathies
    Cerrone, M; Priori, SG.
  • Sudden cardiac death in the young: the molecular autopsy and a practical approach to surviving relatives
    Semsarian, C; Ingles, J; Wilde, AAM.
  • Sudden death in structurally normal heart: we have learned a lot, but still a long way to go
    Brugada, J; Brugada, R.
  • Cardiac abnormalities in first-degree relatives of unexplained cardiac arrest victims A report from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry
    Steinberg, C; Padfield, GJ; Champagne, J; Sanatani, S; Angaran, P; Andrade, JG; Roberts, JD; Healey, JS; Chauhan, VS; Birnie, DH; Janzen, M; Gerull, B; Klein, GJ; Leather, R; Simpson, CS; Seifer, C; Talajic, M; Gardner, M; Krahn, AD.
  • Genetic testing in the evaluation of unexplained cardiac arrest: from the CASPER (Cardiac Arrest Survivors with Preserved Ejection Fraction Registry)
    Mellor, G; Laksman, ZWM; Tadros, R; Roberts, JD; Gerull, B; Simpson, CS; Klein, GJ; Champagne, J; Talajic, M; Gardner, M; Steinberg, C; Arbour, L; Birnie, DH; Angaran, P; Leather, R; Sanatani, S; Chauhan, VS; Seifer, C; Healey, JS; Krahn, AD.
  • 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: association for European Paediatric and Congenital Cardiology (AEPC)
    Priori, SG; Blomström-Lundqvist, C; Mazzanti, A; Blom, N; Borggrefe, M; Camm, J; Elliott, PM; Fitzsimons, D; Hatala, R; Hindricks, G; Kirchhof, P; Kjeldsen, K; Kuck, K-H; Hernandez-Madrid, A; Nikolaou, N; Norekvål, TM; Spaulding, C; Van Veldhuisen, DJ.
  • Survivors of out-of-hospital cardiac arrest with apparently normal heart need for definition and standardized clinical evaluation
  • Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER)
    Krahn, AD; Healey, JS; Chauhan, V; Birnie, DH; Simpson, CS; Champagne, J; Gardner, M; Sanatani, S; Exner, DV; Klein, GJ; Yee, R; Skanes, AC; Gula, LJ; Gollob, MH.
  • Diagnostic approach to unexplained cardiac arrest (from the FIVI-Gen Study)
    Jiménez-Jáimez, J; Peinado, R; Grima, EZ; Segura, F; Moriña, P; Sánchez Muñoz, JJ; Mazuelos, F; Cózar, R; Gimeno, JR; Heras, RP; Monserrat, L; Domingo, D; Ortiz-Genga, M; Fernández Pastor, J; Álvarez, M; Tercedor, L.
  • Outcome of apparently unexplained cardiac arrest: results from investigation and follow-up of the prospective Cardiac Arrest Survivors with Preserved Ejection Fraction Registry
    Herman, ARM; Cheung, C; Gerull, B; Simpson, CS; Birnie, DH; Klein, GJ; Champagne, J; Healey, JS; Gibbs, K; Talajic, M; Gardner, M; Bennett, MT; Steinberg, C; Janzen, M; Gollob, MH; Angaran, P; Yee, R; Leather, R; Chakrabarti, S; Sanatani, S; Chauhan, VS; Krahn, AD.
  • Sudden cardiac death. How to reduce the number of victims?
    Wellens, HJ; De Vreede, J; Gorgels, AP.
  • Risk stratification for sudden cardiac death: current status and challenges for the future
    Wellens, HJJ; Schwartz, PJ; Lindemans, FW; Buxton, AE; Goldberger, JJ; Hohnloser, SH; Huikuri, HV; Kääb, S; La Rovere, MT; Malik, M; Myerburg, RJ; Simoons, ML; Swedberg, K; Tijssen, J; Voors, AA; Wilde, AA.
  • Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
    Elm, EV; Altman, DG; Egger, M; Pocock, SJ; Gotzsche, PC; Vandenbroucke, JP
  • Characteristics and prognosis of sudden cardiac death in Greater Paris: population-based approach from the Paris Sudden Death Expertise Center (Paris-SDEC)
    Bougouin, W; Lamhaut, L; Marijon, E; Jost, D; Dumas, F; Deye, N; Beganton, F; Empana, J-P; Chazelle, E; Cariou, A; Jouven, X.
  • The CAHP (Cardiac Arrest Hospital Prognosis) score: a tool for risk stratification after out-of-hospital cardiac arrest
    Maupain, C; Bougouin, W; Lamhaut, L; Deye, N; Diehl, J-L; Geri, G; Perier, M-C; Beganton, F; Marijon, E; Jouven, X; Cariou, A; Dumas, F.
  • Sudden death expertise centre: a multi disciplinary approach for sudden death
    Marijon, E; Bougouin, W; Cariou, A; Jost, D; Carli, P; Combes, A; Leenhardt, A; Jouven, X
  • Cardiac Arrest and Cardiopulmonary Resuscitation Outcome Reports: update of the Utstein Resuscitation Registry Templates for Out-of-Hospital Cardiac Arrest: a Statement for Healthcare Professionals From a Task Force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian and New Zealand Council on Resuscitation, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Southern Africa, Resuscitation Council of Asia) ;and the American Heart Association Emergency Cardiovascular Care Committee and the Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation
    Perkins, GD; Jacobs, IG; Nadkarni, VM; Berg, RA; Bhanji, F; Biarent, D; Bossaert, LL; Brett, SJ; Chamberlain, D; Caen, AR; de Deakin, CD; Finn, JC; Gräsner, J-T; Hazinski, MF; Iwami, T; Koster, RW; Lim, SH; Ma, MH-M; McNally, BF; Morley, PT; Morrison, LJ; Monsieurs, KG; Montgomery, W; Nichol, G; Okada, K; Ong, MEH; Travers, AH; Nolan, JP
  • Out of hospital cardiac arrest survivors with inconclusive coronary angiogram: impact of cardiovascular magnetic resonance on clinical management and decision-making
    Baritussio, A; Zorzi, A; Dastidar, AG; Susana, A; Mattesi, G; Rodrigues, JCL; Biglino, G; Scatteia, A; Garate, ED; Strange, J; Cacciavillani, L; Iliceto, S; Nisbet, A; Angelini, GD; Corrado, D; Marra, MP; Bucciarelli-Ducci, C.
  • High-resolution three-dimensional late gadolinium-enhanced cardiac magnetic resonance imaging to identify the underlying substrate of ventricular arrhythmia
    Hennig, A; Salel, M; Sacher, F; Camaioni, C; Sridi, S; Denis, A; Montaudon, M; Laurent, F; Jais, P; Cochet, H.
  • Workup of the cardiac arrest survivor: for the symposium on sudden cardiac death for progress in cardiovascular diseases
    Subbiah, R; Gula, LJ; Klein, GJ; Skanes, AC; White, J; Yee, R; Krahn, AD.
  • Diagnosis and management of out-of-hospital cardiac arrest secondary to coronary artery spasm
    Meune, C; Joly, L-M; Chiche, J-D; Charpentier, J; Leenhardt, A; Rozenberg, A; Carli, P; Sauval, P; Weber, S; Cracan, A; Spaulding, C.
  • Characteristics of patients with cardiac arrest caused by coronary vasospasm
    Kobayashi, N; Hata, N; Shimura, T; Yokoyama, S; Shirakabe, A; Shinada, T; Tomita, K; Murakami, D; Takano, M; Seino, Y; Matsumoto, H; Mashiko, K; Mizuno, K.
  • The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol
    Rolf, S; Bruns, H-J; Wichter, T; Kirchhof, P; Ribbing, M; Wasmer, K; Paul, M; Breithardt, G; Haverkamp, W; Eckardt, L.
  • Procainamide infusion in the evaluation of unexplained cardiac arrest: from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER)
    Somani, R; Krahn, AD; Healey, JS; Chauhan, VS; Birnie, DH; Champagne, J; Sanatani, S; Angaran, P; Gow, RM; Chakrabarti, S; Gerull, B; Yee, R; Skanes, AC; Gula, LJ; Leong-Sit, P; Klein, GJ; Gollob, MH; Talajic, M; Gardner, M; Simpson, CS.
  • Diagnosis of unexplained cardiac arrest: role of adrenaline and procainamide infusion
    Krahn, AD; Gollob, M; Yee, R; Gula, LJ; Skanes, AC; Walker, BD; Klein, GJ.
  • Epinephrine infusion in the evaluation of unexplained cardiac arrest and familial sudden death: from the cardiac arrest survivors with preserved Ejection Fraction Registry
    Krahn, AD; Healey, JS; Chauhan, VS; Birnie, DH; Champagne, J; Sanatani, S; Ahmad, K; Ballantyne, E; Gerull, B; Yee, R; Skanes, AC; Gula, LJ; Leong-Sit, P; Klein, GJ; Gollob, MH; Simpson, CS; Talajic, M; Gardner, M.
  • Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome
    Shimizu, W; Noda, T; Takaki, H; Nagaya, N; Satomi, K; Kurita, T; Suyama, K; Aihara, N; Sunagawa, K; Echigo, S; Miyamoto, Y; Yoshimasa, Y; Nakamura, K; Ohe, T; Towbin, JA; Priori, SG; Kamakura, S.
  • Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association
    Antzelevitch, C; Brugada, P; Borggrefe, M; Brugada, J; Brugada, R; Corrado, D; Gussak, I; LeMarec, H; Nademanee, K; Perez Riera, AR; Shimizu, W; Schulze-Bahr, E; Tan, H; Wilde, A.
  • International standardization of diagnostic criteria for vasospastic angina
    Beltrame, JF; Crea, F; Kaski, JC; Ogawa, H; Ong, P; Sechtem, U; Shimokawa, H; Merz, B; Noel, C.
  • Ventricular fibrillation in the Wolff-Parkinson-White syndrome
    Klein, GJ; Bashore, TM; Sellers, TD; Pritchett, EL; Smith, WM; Gallagher, JJ.
  • Short-coupled variant of torsade de pointes. A new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias
    Leenhardt, A; Glaser, E; Burguera, M; Nürnberg, M; Maison-Blanche, P; Coumel, P.
  • Results of endomyocardial biopsy in patients with spontaneous ventricular tachycardia but without apparent structural heart disease
    Strain, JE; Grose, RM; Factor, SM; Fisher, JD.
  • Late potentials in arrhythmogenic right ventricular dysplasia. Prevalence, diagnostic and prognostic values
    Leclercq, JF; Coumel, P.
  • Benefits and limits of selective right ventricular cineangiography in arrhythmogenic right ventricular dysplasia
    Daubert, C; Mabo, P; Druelles, P; Foulgoc, JL; De Place, C; Paillard, F.
  • Diagnosis of arrhythmogenic right ventricular cardiomyopathy by Fourier analysis of gated blood pool single-photon emission tomography
    Casset-Senon, D; Philippe, L; Babuty, D; Eder, V; Fauchier, L; Fauchier, JP; Pottier, JM; Cosnay, P.
  • Diagnostic value of endomyocardial biopsy guided by electroanatomic voltage mapping in arrhythmogenic right ventricular cardiomyopathy/dysplasia
    Avella, A; d'Amati, G; Pappalardo, A; Re, F; Silenzi, P; Laurenzi, F; de Girolamo, P; Pelargonio, G; Russo, A; Baratta, P; Messina, G; Zecchi, P; Zachara, E; Tondo, C.
  • Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes
    Priori, SG; Wilde, AA; Horie, M; Cho, Y; Behr, ER; Berul, C; Blom, N; Brugada, J; Chiang, C-E; Huikuri, H; Kannankeril, P; Krahn, A; Leenhardt, A; Moss, A; Schwartz, PJ; Shimizu, W; Tomaselli, G; Tracy, C; Reviewers, D; Ackerman, M; Belhassen, B; Estes, NAM; Fatkin, D; Kalman, J; Kaufman, E; Kirchhof, P; Schulze-Bahr, E; Wolpert, C; Vohra, J; Refaat, M; Etheridge, SP; Campbell, RM; Martin, ET; Quek, SC
  • Penetrance and risk profile in inherited cardiac diseases studied in a dedicated screening clinic
    Gimeno, JR; Lacunza, J; García-Alberola, A; Cerdán, MC; Oliva, MJ; García-Molina, E; López-Ruiz, M; Castro, F; González-Carrillo, J; de la Morena, G; Valdés, M.
  • Cascades or waterfalls, the cataracts of genetic screening are being opened on clinical cardiology
    Schwartz, PJ.
  • The genetics underlying idiopathic ventricular fibrillation: a special role for catecholaminergic polymorphic ventricular tachycardia?
    Leinonen, JT; Crotti, L; Djupsjöbacka, A; Castelletti, S; Junna, N; Ghidoni, A; Tuiskula, AM; Spazzolini, C; Dagradi, F; Viitasalo, M; Kontula, K; Kotta, M-C; Widén, E; Swan, H; Schwartz, PJ.
  • Idiopathic ventricular fibrillation
    Viskin, S; Belhassen, B.
  • True idiopathic ventricular fibrillation in out-of-hospital cardiac arrest survivors in the Swiss Canton Ticino: prevalence, clinical features, and long-term follow-up
    Conte, G; Caputo, ML; Regoli, F; Marcon, S; Klersy, C; Adjibodou, B; Del Bufalo, A; Moccetti, T; Auricchio, A.
  • Primary prevention of idiopathic ventricular fibrillation: not for the faint of heart
    Adler, A; Gollob, MH.
  • Opening a new front in the fight against sudden cardiac death: is it time for near-term prevention?
    Karam, N; Marijon, E; Jouven, X.
  • Warning symptoms are associated with survival from sudden cardiac arrest
    Marijon, E; Uy-Evanado, A; Dumas, F; Karam, N; Reinier, K; Teodorescu, C; Narayanan, K; Gunson, K; Jui, J; Jouven, X; Chugh, SS
  • Evolution of clinical diagnosis in patients presenting with unexplained cardiac arrest or syncope due to polymorphic ventricular tachycardia
    Vittoria Matassini, M; Krahn, AD; Gardner, M; Champagne, J; Sanatani, S; Birnie, DH; Gollob, MH; Chauhan, V; Simpson, CS; Hamilton, RM; Talajic, M; Ahmad, K; Gerull, B; Chakrabarti, S; Healey, JS.
  • What to do in patients with no structural heart disease and sudden arrhythmic death?
    Brugada, J; Brugada, P.